glp 1 pancreatitis A new study showed that use of the GLP1 agonist medications approved for diabetes and weight loss including liraglutide (Victoza, Saxenda) & semaglutide (Ozempic, Wegovy, Rybelsus) come with a 9X increased risk Schematic presentation of the function
Description
Armstrong AW, Harskamp CT, Armstrong EJ
WEIGHT LOSS EDUCATION Chronos GLP-1 Weight Loss Program Patient Education Hub Welcome to the Chronos Body Health & Wellness Weight Loss Education Center

Who is most at risk of eye problems from GLP-1 treatments

doi: 10.1016/j.molmet.2016.11.008

Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis
